Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A13474 | 29956209 | Adv Exp Med Biol | The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease. | 2018 | Details |
A13476 | 29956207 | Adv Exp Med Biol | Hepatocellular Carcinoma in Obesity: Finding a Needle in the Haystack? | 2018 | Details |
A13477 | 29956206 | Adv Exp Med Biol | NAFLD Related-HCC: The Relationship with Metabolic Disorders. | 2018 | Details |
A13478 | 29956205 | Adv Exp Med Biol | Chemokines and Chemokine Receptors in the Development of NAFLD. | 2018 | Details |
A13479 | 29956204 | Adv Exp Med Biol | Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease. | 2018 | Details |
A13480 | 29956203 | Adv Exp Med Biol | Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC. | 2018 | Details |
A13481 | 29956202 | Adv Exp Med Biol | Introduction. | 2018 | Details |
A13482 | 29956192 | Adv Exp Med Biol | Developmental Origins of Nonalcoholic Fatty Liver Disease (NAFLD). | 2018 | Details |
A13485 | 29954288 | J Bioinform Comput Biol | Succinate aggravates NAFLD progression to liver cancer on the onset of obesity: An in silico model. | 2018 | Details |
A13486 | 29954129 | Int J Mol Sci | Insights into the Role of PPARβ/δ in NAFLD. | 2018 | Details |
A13487 | 29953740 | Basic Clin Pharmacol Toxicol | Liraglutide Decreases Hepatic Inflammation and Injury in Advanced Lean Non-Alcoholic Steatohepatitis. | 2018 | Details |
A13494 | 29949199 | J Gastroenterol Hepatol | Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients. | 2018 | Details |
A13495 | 29948900 | Sci China Life Sci | Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients. | 2018 | Details |
A13498 | 29947322 | Br J Nutr | Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. | 2018 | Details |
A13500 | 29947103 | Eur J Clin Invest | Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease. | 2018 | Details |
A13504 | 29945982 | J Endocrinol | INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function. | 2018 | Details |
A13508 | 29942422 | J Clin Aesthet Dermatol | A Case-control Study to Evaluate the Prevalence of Nonalcoholic Fatty Liver Disease Among Patients with Moderate-to-severe Psoriasis. | 2018 | Details |
A13509 | 29942096 | Nat Med | Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. | 2018 | Details |
A13510 | 29941024 | Trials | Effects of an exercise program on hepatic metabolism, hepatic fat, and cardiovascular health in overweight/obese adolescents from Bogotá, Colombia (the HEPAFIT study): study protocol for a randomized controlled trial. | 2018 | Details |
A13512 | 29940269 | J Hepatol | Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. | 2018 | Details |
A13523 | 29931613 | Curr Diab Rep | The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes. | 2018 | Details |
A13530 | 29929399 | Ann Med | The association of non-alcoholic fatty liver disease and atrial fibrillation: a review. | 2018 | Details |
A13531 | 29928260 | Front Endocrinol (Lausanne) | Liver Enlargement Predicts Obstructive Sleep Apnea-Hypopnea Syndrome in Morbidly Obese Women. | 2018 | Details |
A13532 | 29928018 | PLoS One | Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH). | 2018 | Details |
A13538 | 29924722 | Biol Chem | Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk. | 2018 | Details |
A13540 | 29924135 | Braz J Med Biol Res | Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease. | 2018 | Details |
A13543 | 29921793 | Cells | Endoplasmic Reticulum Stress in Metabolic Disorders. | 2018 | Details |
A13545 | 29920701 | Aliment Pharmacol Ther | Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B. | 2018 | Details |
A13550 | 29915740 | J Family Med Prim Care | A study on the altered glycemic and lipid parameters and prevalence of insulin resistance in nonalcoholic fatty liver disease. | 2022 | Details |
A13551 | 29915639 | Gastroenterology Res | A Case of Concomitant Obstructive Sleep Apnea and Non-Alcoholic Steatohepatitis Treated With CPAP Therapy. | 2018 | Details |
A13552 | 29913455 | Cells Tissues Organs | Grape Leucoanthocyanidin Protects Liver Tissue in Albino Rabbits with Nonalcoholic Hepatic Steatosis. | 2018 | Details |
A13559 | 29912573 | Arch Physiol Biochem | Association of tissue inhibitor of metalloproteinase 2 with non-alcoholic fatty liver disease in metabolic syndrome. | 2018 | Details |
A13567 | 29904722 | Clin Exp Hepatol | Underrated enemy - from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract. | 2018 | Details |
A13568 | 29904577 | F1000Res | Surgical treatment of obesity. | 2018 | Details |
A13572 | 29902703 | Atherosclerosis | Metabolic liver inflammation in obesity does not robustly decrease hepatic and circulating CETP. | 2018 | Details |
A13577 | 29898626 | Adipocyte | Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance. | 2018 | Details |
A13584 | 29895006 | Front Horm Res | The Metabolic Syndrome in Central Hypogonadotrophic Hypogonadism. | 2018 | Details |
A13586 | 29893699 | Ann Hepatol | Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese. | 2019 | Details |
A13587 | 29893698 | Ann Hepatol | Association Between Serum Hemoglobin Levels and Non Alcoholic Fatty Liver Disease in a Mexican Population. | 2019 | Details |
A13589 | 29892281 | Front Immunol | Distinct Housing Conditions Reveal a Major Impact of Adaptive Immunity on the Course of Obesity-Induced Type 2 Diabetes. | 2018 | Details |
A13599 | 29886156 | J Hepatol | Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. | 2018 | Details |
A13600 | 29885082 | Diabetes Obes Metab | No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease. | 2018 | Details |
A13605 | 29881818 | Hepatol Commun | Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease. | 2018 | Details |
A13612 | 29878845 | Am J Physiol Gastrointest Liver Physiol | Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis. | 2018 | Details |
A13613 | 29877264 | Intern Med | A Young Man with Non-alcoholic Steatohepatitis and Serum Anti-mitochondrial Antibody Positivity. | 2018 | Details |
A13614 | 29874807 | Med Sci (Basel) | The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A13626 | 29866129 | BMC Gastroenterol | Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial. | 2018 | Details |
A13628 | 29864682 | J Nutr Biochem | Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids. | 2018 | Details |
A13637 | 29860108 | Atherosclerosis | Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver. | 2018 | Details |
A13638 | 29860102 | J Nutr Biochem | Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet. | 2018 | Details |
A13646 | 29858436 | Clin Med (Lond) | Non-alcoholic fatty liver disease. | 2018 | Details |
A13652 | 29855396 | J Dev Orig Health Dis | Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice. | 2018 | Details |
A13654 | 29854716 | Can J Gastroenterol Hepatol | Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children. | 2018 | Details |
A13655 | 29854715 | Can J Gastroenterol Hepatol | Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children. | 2018 | Details |
A13656 | 29853957 | Evid Based Complement Alternat Med | Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A13659 | 29852170 | Biochem Biophys Res Commun | Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice. | 2018 | Details |
A13663 | 29849912 | Oxid Med Cell Longev | The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases: Links and Interactions. | 2018 | Details |
A13672 | 29845719 | Intern Med J | Non-alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence. | 2018 | Details |
A13673 | 29845362 | Wien Klin Wochenschr | Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease. | 2018 | Details |
A13678 | 29844386 | Nat Commun | The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. | 2018 | Details |
A13681 | 29843693 | BMC Surg | First right lobe living-donor hepatectomy after sleeve gastrectomy. | 2018 | Details |
A13683 | 29808958 | Clin Physiol Funct Imaging | Cardiometabolic effects of antidiabetic drugs in non-alcoholic fatty liver disease. | 2018 | Details |
A13688 | 29804898 | Trends Endocrinol Metab | Sleeve Gastrectomy: Metabolic Surgical Procedure of Choice? | 2018 | Details |
A13689 | 29804707 | Asian J Surg | HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis. | 2018 | Details |
A13692 | 29803928 | Biomed Pharmacother | Protective effects of cichoric acid on H2O2-induced oxidative injury in hepatocytes and larval zebrafish models. | 2018 | Details |
A13693 | 29803897 | Clin Chim Acta | Uric acid and cardiovascular disease. | 2018 | Details |
A13695 | 29803210 | Neuro Endocrinol Lett | Shall we diagnose metabolic syndrome in adolescents? | 2018 | Details |
A13698 | 29802679 | J Diabetes Investig | Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis. | 2018 | Details |
A13700 | 29802399 | Sci Rep | Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis. | 2018 | Details |
A13701 | 29802129 | Diabetes | Production of Elastin-Derived Peptides Contributes to the Development of Nonalcoholic Steatohepatitis. | 2018 | Details |
A13708 | 29798686 | Syst Biol Reprod Med | Effects of saturated palmitic acid and omega-3 polyunsaturated fatty acids on Sertoli cell apoptosis. | 2018 | Details |
A13709 | 29797529 | Aliment Pharmacol Ther | Physical deconditioning is the common denominator in both obese and overweight subjects with nonalcoholic steatohepatitis. | 2018 | Details |
A13710 | 29797516 | Eur J Clin Invest | Exercising the hepatobiliary-gut axis. The impact of physical activity performance. | 2018 | Details |
A13713 | 29795696 | PLoS One | Correction: Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach. | 2018 | Details |
A13714 | 29795358 | Acta Pharmacol Sin | Novel substituted pyrazolone derivatives as AMP-activated protein kinase activators to inhibit lipid synthesis and reduce lipid accumulation in ob/ob mice. | 2018 | Details |
A13715 | 29795111 | Cell Death Dis | Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development. | 2018 | Details |
A13717 | 29793999 | Diabetes | The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders. | 2018 | Details |
A13722 | 29791248 | Metab Syndr Relat Disord | ddY Mice Fed 10% Fat Diet Exhibit High p27KIP Expression and Delayed Hepatocyte DNA Synthesis During Liver Regeneration. | 2018 | Details |
A13723 | 29791184 | Child Obes | A Narrative Review of Medical and Genetic Risk Factors among Children Age 5 and Younger with Severe Obesity. | 2018 | Details |
A13725 | 29789866 | Cell Mol Life Sci | Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation. | 2018 | Details |
A13726 | 29788220 | Endocrinology | Obstructive Sleep Apnea Syndrome and Metabolic Diseases. | 2018 | Details |
A13733 | 29785393 | Psoriasis (Auckl) | Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography. | 2018 | Details |
A13736 | 29785076 | World J Gastroenterol | Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease. | 2018 | Details |
A13739 | 29783208 | Wiad Lek | The role of hydrogen sulfide in the progression mechanisms of non-alcoholic steatohepatitis and chronic kidney disease. | 2018 | Details |
A13744 | 29779170 | Eur J Nutr | Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial. | 2018 | Details |
A13748 | 29778128 | J Natl Med Assoc | The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients. | 2017 | Details |
A13749 | 29777749 | J Hepatol | Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. | 2018 | Details |
A13756 | 29772784 | Nutrients | Capsaicin in Metabolic Syndrome. | 2018 | Details |
A13759 | 29770757 | Br J Nutr | Soya protein β-conglycinin ameliorates fatty liver and obesity in diet-induced obese mice through the down-regulation of PPARγ. | 2018 | Details |
A13762 | 29769484 | Mymensingh Med J | Prevalence of Non-Alcoholic Fatty Liver Disease and Its Biochemical Predictors in Patients with Type-2 Diabetes Mellitus. | 2018 | Details |
A13765 | 29766824 | Curr Stem Cell Res Ther | Adipose-derived Mesenchymal Stem Cells in the Treatment of Obesity: A Systematic Review of Longitudinal Studies on Preclinical Evidence. | 2018 | Details |
A13768 | 29766791 | Curr Pharm Des | Immunometabolic Changes in Hepatocytes Arising from Obesity and the Practice of Physical Exercise. | 2018 | Details |
A13770 | 29765172 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | Dietary sucrose regulates the expression of the Cd36 gene in hepatic tissue of rats with obesity and Non Alcoholic Fatty Liver Disease (NAFLD). | 2018 | Details |
A13772 | 29764990 | Sci Signal | IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs. | 2018 | Details |
A13773 | 29764908 | Eur J Endocrinol | MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass. | 2018 | Details |
A13776 | 29762096 | Radiology | US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A13780 | 29761170 | Hepatol Commun | Nicotinamide adenine dinucleotide phosphate (reduced) oxidase 2 modulates inflammatory vigor during nonalcoholic fatty liver disease progression in mice. | 2018 | Details |
A13781 | 29760679 | Front Endocrinol (Lausanne) | Hematocrit Values Predict Carotid Intimal-Media Thickness in Obese Patients With Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study. | 2018 | Details |
A13787 | 29757972 | Biomedicines | Short-Term Soy Protein Isolate Feeding Prevents Liver Steatosis and Reduces Serum ALT and AST Levels in Obese Female Zucker Rats. | 2018 | Details |
A13788 | 29757947 | Biomolecules | Membrane Remodeling as a Key Player of the Hepatotoxicity Induced by Co-Exposure to Benzo[a]pyrene and Ethanol of Obese Zebrafish Larvae. | 2018 | Details |